Home / Clinical trials / Somatropin
Are there clinical trials for Somatropin?
Somatropin has 817 registered clinical trials, including 392 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Trial breakdown
By phase
| Phase 3 | 183 |
| Phase 2 | 169 |
| Not applicable | 130 |
| Phase 4 | 91 |
| Phase 1 | 81 |
| Early Phase 1 | 7 |
By status
| Completed | 523 |
| Unknown status | 104 |
| Terminated | 68 |
| Recruiting | 46 |
| Withdrawn | 35 |
| Not yet recruiting | 16 |
| Active, not recruiting | 14 |
| Enrolling by invitation | 8 |
| Suspended | 3 |
Active trials
- Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone DeficiencyPhase 3 · Not yet recruiting · 150 participants · Lumos Pharma · started 2027-02NCT07129759
- Human Models of Selective Insulin Resistance: Pancreatic ClampPhase 1 · Not yet recruiting · 36 participants · Columbia University · started 2027-01-01NCT06558422
- Investigation of Growth Hormone and Platelet-Rich Plasma on Joint HealthPhase 2 / Phase 3 · Not yet recruiting · 192 participants · Integrant Pty Ltd · started 2026-11NCT06907121
- Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short StaturePhase 3 · Not yet recruiting · 240 participants · Zhongshan Sansure Hygene Biomedicine Co., Ltd. · started 2026-09NCT07815626
- Growth Hormone Resistance of Beta-cellsNot yet recruiting · 10 participants · University of Missouri-Columbia · started 2026-08-01NCT07581860
- AAVrh10-PCCA Gene Therapy for Propionic AcidemiaPhase 1 · Recruiting · 9 participants · Mayo Clinic · started 2026-07-20NCT07643844
- Direct Versus Video Laryngoscopy in Patients With AcromegalyNot yet recruiting · 40 participants · Muzaffer GENCER · started 2026-07-01NCT07659912
- Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 LevelsNot applicable · Not yet recruiting · 300 participants · Cliniques universitaires Saint-Luc- Université Catholique de Louvain · started 2026-07-01NCT07173036
Most recent registered trials
- Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone DeficiencyPhase 3 · Not yet recruiting · 150 participants · Lumos Pharma · started 2027-02NCT07129759
- Human Models of Selective Insulin Resistance: Pancreatic ClampPhase 1 · Not yet recruiting · 36 participants · Columbia University · started 2027-01-01NCT06558422
- Investigation of Growth Hormone and Platelet-Rich Plasma on Joint HealthPhase 2 / Phase 3 · Not yet recruiting · 192 participants · Integrant Pty Ltd · started 2026-11NCT06907121
- Phase 3 Study to Evaluate the Efficacy and Safety of Human Growth Hormone Injection (Sinotropin AQ) for the Treatment of Children With Idiopathic Short StaturePhase 3 · Not yet recruiting · 240 participants · Zhongshan Sansure Hygene Biomedicine Co., Ltd. · started 2026-09NCT07815626
- Growth Hormone Resistance of Beta-cellsNot yet recruiting · 10 participants · University of Missouri-Columbia · started 2026-08-01NCT07581860
- AAVrh10-PCCA Gene Therapy for Propionic AcidemiaPhase 1 · Recruiting · 9 participants · Mayo Clinic · started 2026-07-20NCT07643844
- Direct Versus Video Laryngoscopy in Patients With AcromegalyNot yet recruiting · 40 participants · Muzaffer GENCER · started 2026-07-01NCT07659912
- Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 LevelsNot applicable · Not yet recruiting · 300 participants · Cliniques universitaires Saint-Luc- Université Catholique de Louvain · started 2026-07-01NCT07173036
- Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone DeficiencyPhase 2 · Recruiting · 36 participants · Xiamen Amoytop Biotech Co., Ltd. · started 2026-06-10NCT07551804
- The AgRP and GH/IGF-1 Axis in ChildrenNot yet recruiting · 156 participants · Columbia University · started 2026-06-10NCT05645211
- GB06 Phase III Trial for Pediatric Growth Hormone DeficiencyPhase 3 · Recruiting · 192 participants · Kexing Biopharm Co., Ltd. · started 2026-06-06NCT07553351
- Phase 3 Study of LUM-201 in Children With Growth Hormone DeficiencyPhase 3 · Recruiting · 150 participants · Lumos Pharma · started 2026-05-20NCT06948214
Frequently asked questions
Are there clinical trials for Somatropin?
Somatropin has 817 registered clinical trials, including 392 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where Somatropin is registered as an intervention. Last updated 2026-09-23.